ATRA Atara Biotherapeutics, Inc.

Fundamentals / CIK 0001604464 / USD

Atara Biotherapeutics, Inc. reported $3.96M in revenue and a net loss of $14.61M for the trailing twelve months ended September 30, 2026 (down 64.6% year over year), with a -343.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$163.0M$81.50M$0-$329.0MFY 2016 Net Income: -$79.05M2016FY 2017 Net Income: -$119.5M2017FY 2018 Net Income: -$230.7M2018FY 2019 Net Income: -$291.0M2019FY 2020 Net Income: -$306.6M2020FY 2021 Net Income: -$340.1M2021FY 2022 Revenue: $63.57MFY 2022 Net Income: -$228.3M2022FY 2023 Revenue: $8.57MFY 2023 Net Income: -$276.1M2023FY 2024 Revenue: $128.9MFY 2024 Net Income: -$85.40M2024FY 2025 Revenue: $120.8MFY 2025 Net Income: $32.69M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $120.8M $128.9M $8.57M $63.57M -- -- -- -- -- --
Research & Development $37.45M $151.5M $224.8M $272.5M $282.0M $244.7M $216.1M $167.5M $81.21M $56.51M
Total Operating Expenses -- -- -- $344.1M $360.8M $309.1M $295.7M $237.1M $121.5M $81.24M
Operating Income $35.86M -$83.44M -$276.0M -$280.5M -$340.5M -$309.1M -$295.7M -$237.1M -$121.5M -$81.24M
EBITDA $37.98M -$78.39M -$271.2M -$274.9M -$331.1M -$300.7M -$288.6M -$233.4M -$120.6M -$80.86M
Interest Income $683K $2.11M $5.43M $3.06M -- -- -- -- -- --
Interest Expense $3.79M $4.62M $5.29M $373K -- -- -- -- -- --
Income Before Tax $32.72M -$85.42M -$276.1M -$228.3M -$340.1M -$306.6M -$291.0M -$230.7M -$119.5M -$79.04M
Income Tax Expense $31K -$12K $15K $12K $46K $15K $12K -$44K -$14K $10K
Net Income $32.69M -$85.40M -$276.1M -$228.3M -$340.1M -$306.6M -$291.0M -$230.7M -$119.5M -$79.05M
Basic EPS $2.61 -$11.41 -$65.19 -$56.00 -$90.75 -$103.75 -$141.75 -$131.75 -$100.00 -$68.75
Diluted EPS $2.57 -$11.41 -$65.19 -$56.00 -$90.75 -$103.75 -$141.75 -$131.75 -$100.00 -$68.75
Basic Shares Outstanding 12.5M 7.5M 4.2M 4.1M 3.7M 3.0M 2.1M 1.8M 1.2M 1.1M
Diluted Shares Outstanding 12.7M 7.5M 4.2M 4.1M 3.7M 3.0M 2.1M 1.8M 1.2M 1.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.22M $630K $516K $1.59M $3.45M $17.57M $98.15M $32.75M
Cost of Revenue $265K -- -- -- $115K -- -- --
Gross Profit $959K -- -- -- $3.34M -- -- --
Research & Development $1.10M $1.34M $164K -$223K $2.92M $7.31M $27.43M $28.72M
Operating Income -$2.97M -$4.72M -$3.37M -$2.56M -$3.57M $3.20M $38.80M -$12.20M
EBITDA -$2.97M -$4.71M -$3.34M -$2.51M -$3.54M $3.43M $40.60M -$11.10M
Interest Income $68K $78K $54K $100K $204K $143K $236K $597K
Interest Expense -- $191K $830K $894K $909K $972K $1.02M $1.02M
Income Before Tax -$2.23M -$4.83M -$4.14M -$3.41M -$4.28M $2.39M $38.01M -$12.71M
Income Tax Expense $0 $1.0K $0 $0 $28K $3.0K $0 -$19K
Net Income -$2.23M -$4.83M -$4.14M -$3.41M -$4.30M $2.39M $38.01M -$12.69M
Basic EPS -$0.15 -$0.32 -$0.29 -- -$0.32 $0.20 $3.53 --
Diluted EPS -$0.15 -$0.32 -$0.29 -- -$0.32 $0.19 $3.50 --
Basic Shares Outstanding 15.3M 15.0M 14.1M -- 13.6M 12.2M 10.8M --
Diluted Shares Outstanding 15.3M 15.0M 14.1M -- 13.6M 12.3M 10.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.48M $25.03M $25.84M $92.94M $106.1M $200.4M $74.32M $60.70M $79.22M $47.97M
Short-Term Investments $0 $17.47M $25.88M $149.9M $265.0M $300.3M $184.8M $248.9M $86.87M $207.7M
Cash & Short-Term Investments $8.50M $42.50M $51.73M $242.8M $371.1M $500.7M $259.1M $309.6M $166.1M $255.7M
Accounts Receivable, Net $1.25M $1.48M $34.11M $40.22M $986K $1.25M $0 -- -- --
Inventory $0 $10.65M $9.71M $1.59M $0 -- -- -- -- --
Other Current Assets $2.48M $10.12M $6.18M $10.31M $12.37M -- -- -- -- --
Total Current Assets $12.21M $64.89M $101.9M $295.1M $384.6M $523.3M $273.0M $321.5M $172.2M $260.6M
Property, Plant & Equipment, Net $73K $1.29M $3.86M $6.30M $53.78M $50.52M $54.18M $68.58M $44.13M $3.26M
Other Non-Current Assets $886K $3.10M $4.84M $7.02M $2.37M $827K $567K $574K $260K $102K
Total Non-Current Assets $8.02M $44.20M $63.63M $81.34M $83.51M $64.85M $69.95M $70.35M $45.59M $3.36M
Total Assets $20.23M $109.1M $165.5M $376.4M $468.1M $588.1M $342.9M $391.8M $217.8M $263.9M
Accounts Payable $127K $4.37M $3.68M $6.87M $17.37M $7.12M $7.96M $3.72M $14.71M $2.78M
Deferred Revenue (Current) $716K -- $77.83M -- -- $33.45M -- -- -- --
Other Current Liabilities $2.98M $20.16M $31.83M $21.39M $9.06M $6.06M $5.73M $6.41M $3.27M $744K
Total Current Liabilities $14.92M $134.6M $142.2M $78.92M $105.8M $82.90M $36.74M $39.98M $27.65M $9.68M
Deferred Revenue (Non-Current) -- $0 $37.56M $77.00M $55.71M $27.80M -- -- -- --
Other Non-Current Liabilities $1.79M $3.27M $4.63M $5.56M $1.50M $2.04M $1.28M $13.00M -- --
Total Non-Current Liabilities $43.81M $71.81M $122.5M $170.9M $82.73M $42.88M $15.42M $13.00M $12.27M $503K
Total Liabilities $58.74M $206.4M $264.7M $249.8M $188.5M $125.8M $52.16M $52.98M $39.91M $10.18M
Total Debt (incl. Leases) $10.38M $45.43M $60.49M $75.35M $28.30M $15.18M $15.96M $587K -- --
Common Stock $1.0K $1.0K $0 $10K $9.0K $8.0K $6.0K $5.0K $3.0K $3.0K
Retained Earnings -$2.02B -$2.05B -$1.97B -$1.69B -$1.46B -$1.12B -$818.0M -$527.3M -$296.6M -$177.2M
Accumulated Other Comp. Income $1.0K $8.0K -$204K -$2.07M -$368K $296K $220K -$340K -$151K -$183K
Total Stockholders' Equity -$38.50M -$97.28M $99.23M $126.6M $279.6M $462.3M $290.8M $339.2M $177.9M $253.7M
Total Equity -$38.50M -$97.28M $99.23M $126.6M $279.6M $462.3M $290.8M $339.2M $177.9M $253.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.05M $3.22M $8.36M $8.48M $5.74M $16.90M $13.84M $25.03M
Short-Term Investments $5.86M $6.65M -- $0 $7.97M $5.42M $0 $17.47M
Cash & Short-Term Investments $9.90M $9.90M $8.36M $8.50M $13.71M $22.32M $13.84M $42.50M
Accounts Receivable, Net $691K $318K $0 $1.25M $1.91M $0 $8.88M $1.48M
Inventory -- -- -- $0 $0 $0 $0 $10.65M
Other Current Assets $705K $3.34M $3.81M $2.48M $2.81M $2.45M $4.32M $10.12M
Total Current Assets $11.31M $13.53M $12.17M $12.21M $18.43M $24.77M $27.18M $64.89M
Property, Plant & Equipment, Net $38K $41K $55K $73K $147K $176K $285K $1.29M
Other Non-Current Assets $762K $765K $890K $886K $881K $927K $2.84M $3.10M
Total Non-Current Assets $7.29M $7.49M $7.82M $8.02M $11.73M $12.13M $34.86M $44.20M
Total Assets $18.61M $21.02M $20.00M $20.23M $30.17M $36.90M $62.04M $109.1M
Accounts Payable $762K $824K $637K $127K $318K $1.76M $1.38M $4.37M
Deferred Revenue (Current) $513K -- -- $716K -- -- -- --
Other Current Liabilities $3.69M $3.46M $2.94M $2.98M $4.65M $7.67M $24.14M $20.16M
Total Current Liabilities $6.57M $6.85M $5.64M $14.92M $18.06M $14.56M $47.89M $134.6M
Deferred Revenue (Non-Current) $0 -- -- -- -- $0 $0 $0
Other Non-Current Liabilities $1.90M $1.89M $1.83M $1.79M $1.76M $1.73M $3.13M $3.27M
Total Non-Current Liabilities $49.94M $51.17M $51.66M $43.81M $48.74M $57.38M $69.22M $71.81M
Total Liabilities $56.51M $58.02M $57.31M $58.74M $66.80M $71.94M $117.1M $206.4M
Total Debt (incl. Leases) $9.57M $9.88M $10.09M $10.38M $16.96M $17.67M $41.94M $45.43M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$2.03B -$2.03B -$2.03B -$2.02B -$2.02B -$2.01B -$2.02B -$2.05B
Accumulated Other Comp. Income -$1.0K -$2.0K $0 $1.0K $2.0K $0 $0 $8.0K
Total Stockholders' Equity -$37.90M -$37.00M -$37.31M -$38.50M -$36.63M -$35.04M -$55.07M -$97.28M
Total Equity -$37.90M -$37.00M -$37.31M -$38.50M -$36.63M -$35.04M -$55.07M -$97.28M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $32.69M -$85.40M -$276.1M -$228.3M -$340.1M -$306.6M -$291.0M -$230.7M -$119.5M -$79.05M
Depreciation & Amortization $2.12M $5.05M $4.83M $5.65M $9.35M $8.33M $7.07M $3.73M $956K $383K
Stock-Based Compensation $9.75M $27.00M $45.39M $53.84M $53.87M $51.35M $51.70M $33.82M $23.10M $16.78M
Change in Receivables $229K $32.63M $6.11M -$39.23M $264K -$1.25M $0 $0 -- --
Change in Inventory $10.65M -$4.43M -$8.12M -$1.59M $0 $0 -- -- -- --
Change in Payables -$4.24M $687K -$3.13M -$9.21M $9.07M -$815K $4.21M -$1.96M $2.16M $981K
Operating Cash Flow -$50.94M -$68.72M -$193.0M -$270.4M -$220.5M -$180.8M -$235.6M -$179.8M -$87.50M -$60.02M
Capital Expenditure $0 -$246K -$1.22M -$4.19M -$10.58M -$4.51M -$5.73M -$35.92M -$20.23M -$3.02M
Free Cash Flow -$50.94M -$68.96M -$194.2M -$274.6M -$231.1M -$185.3M -$241.4M -$215.7M -$107.7M -$63.05M
Investing Cash Flow $18.15M $8.62M $123.9M $203.0M $22.26M -$120.7M $60.46M -$196.3M $99.91M $83.74M
Common Stock Issued $1.47M $9.35M $2.14M $21.89M $98.70M $69.19M $47.73M $47.59M $19.16M $0
Financing Cash Flow $16.10M $59.28M $2.01M $53.08M $103.9M $427.6M $188.8M $357.5M $20.05M $506K
Net Change in Cash -$16.69M -$811K -$67.10M -$14.39M -$94.32M $126.1M $13.62M -$18.52M $31.25M $24.22M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.23M -$4.83M -$4.14M -$3.41M -$4.30M $2.39M $38.01M -$12.69M
Depreciation & Amortization $3.0K $14K $29K $49K $36K $236K $1.79M $1.10M
Stock-Based Compensation $457K $394K $749K $1.52M $1.23M $2.80M $4.21M $5.85M
Change in Receivables -$373K -$318K $1.25M $660K -$1.91M $8.88M -$7.39M -$147K
Change in Inventory -- $0 $0 $0 $0 $0 $10.65M -$160K
Change in Payables -$62K $187K $510K -$191K -$983K -$83K -$2.98M $2.22M
Operating Cash Flow -$879K -$3.34M -$3.07M -$5.70M -$9.79M -$7.32M -$28.14M -$24.47M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$90K
Free Cash Flow -- -- -- -$5.70M -$9.79M -$7.32M -$28.14M -$24.56M
Investing Cash Flow $833K -$6.63M $0 $8.44M -$2.42M -$5.07M $17.20M $3.38M
Common Stock Issued $880K $4.83M $2.95M -$25K $1.50M $0 $0 $0
Financing Cash Flow $880K $4.83M $2.95M -$3.0K $1.05M $15.30M -$250K -$328K
Net Change in Cash $834K -$5.14M -$122K $2.74M -$11.16M $2.92M -$11.19M -$21.42M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 29.7% -64.7% -3219.5% -441.2% -- -- -- -- -- --
Net Profit Margin 27.1% -66.2% -3220.9% -359.1% -- -- -- -- -- --
Return on Equity (ROE) -- -- -278.3% -180.3% -121.6% -66.3% -100.1% -68.0% -67.2% -31.2%
Return on Assets (ROA) 161.5% -78.3% -166.8% -60.7% -72.7% -52.1% -84.8% -58.9% -54.9% -30.0%
Current Ratio 0.82x 0.48x 0.72x 3.74x 3.64x 6.31x 7.43x 8.04x 6.23x 26.93x
Quick Ratio 0.82x 0.40x 0.65x 3.72x 3.64x 6.05x 7.05x 7.74x 6.01x 26.43x
Debt to Equity -- -- 0.61x 0.59x 0.10x 0.03x 0.05x 0.00x -- --
Revenue Growth (YoY) -6.3% +1404.0% -86.5% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -343.6% -229.7% -27.3% 29.7% 17.3% 4.3% -6.7% -64.7%
Net Profit Margin -368.6% -269.4% -40.9% 27.1% 15.4% 3.1% -7.8% -66.2%
Return on Assets (ROA) -78.5% -79.4% -47.3% 161.5% 77.6% 15.7% -25.2% -78.3%
Current Ratio 1.72x 1.98x 2.16x 0.82x 1.02x 1.70x 0.57x 0.48x
Quick Ratio 1.61x 1.49x 1.48x 0.82x 1.02x 1.70x 0.57x 0.40x
Revenue Growth (YoY) -64.6% -96.4% -99.5% -95.1% -91.4% -38.6% +258.8% +670.3%
Gross Profit Growth (YoY) -71.3% -- -- -- -- -- -- --
Operating Income Growth (YoY) -- -247.6% -108.7% -- -- -- -- --
Net Income Growth (YoY) -- -302.5% -110.9% -- -- -- -- --
EPS Growth (YoY) -- -260.0% -108.2% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001604464) · from September 30, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:50 UTC · Open in terminal